Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Lilly's PTH analogue LY-333334 featured at this week's ASBMR meeting

Oct. 4, 1999

Takeda to collaborate in the development of Dainippon's candidate antidiabetic

Oct. 4, 1999

FDA approves Evista for treatment of postmenopausal osteoporosis

Oct. 1, 1999

Positive results received from interim analysis of Crinone treatment

Oct. 1, 1999

Myriad Genetics identifies diabetes gene

Sep. 29, 1999

UC Irvine and NeoTherapeutics enter research and licensing agreement

Sep. 29, 1999

Results of small clinical study indicate nefazodone may be effective for diabetic neuropathy

Sep. 28, 1999

Acamprosate attenuates food craving in subjects with bulimia nervosa

Sep. 24, 1999

Convenient new insulin mixture by Lilly offers better glycemic control

Sep. 24, 1999

Idun receives SBIR grant for apoptosis inhibitor research

Sep. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...